ESW Launches GovCon Accelerator™: A First-of-Its-Kind Framework for Secure, Compliance-Driven Microsoft 365 Deployments in GCC High 
Indonesia’s Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership 
Tradelink and Fadada Sign Strategic Agreement to Promote Secure Cross-Border Digital Signing Solutions in Hong Kong Parasto Momeni is the Subject of a New Interview
The renowned chef, caterer, and entrepreneur sat down with a freelance journalist to discuss her…
Condor Gold Plc: 6.6 m True Width at 10.51 g/t Gold Amongst Final Drilling Results from 3,370 m Drilling Programme
SURREY, BC / ACCESSWIRE / August 19, 2021 / Condor Gold (AIM:CNR)(TSX:COG) is pleased to…
Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / August 19, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: RLF,…
HIVE Blockchain Announces The Appointment of Aydin Kilic as President and Chief Operating Officer
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Victoria University Online Opens Next Intake for its 100% Online Master of Business Administration (Finance)
VU Online has announced the next intake for its popular online MBA (Finance), with enrolments…
Latest Figures From Leading Web Hosting Companies Show Prices Remain Unchanged in 2021
Shared Hosting prices, according to the latest figures by WebHostingSecretsRevaled (WHSR), show that pricing has…
Pono Capital Corp Announces Closing of Underwriters’ Option to Purchase Additional Units in Connection with its Initial Public Offering
HONOLULU, HI / ACCESSWIRE / August 18, 2021 / Pono Capital Corp (the “Company”) today…
NexgenRx Announces Financial Results for Q2 2021 With Continued Growth in Revenues and Adjusted EBITDA
TORONTO, ON / ACCESSWIRE / August 18, 2021 / NEXGENRX INC. (TSXV:NXG) (“NexgenRx” or the…
Endace Celebrates 20th Anniversary with Donation to The Glaucoma Foundation
Corporate gift provides dollar-for-dollar matching to donations received in the 2021 TGF Art Challenge to…
Westcon-Comstor expands Sandvine distribution agreement across EMEA and APAC
Leading technology distributor appointed strategic distributor for Sandvine LONDON, UK – 19th August 2021 –…
Thomas Christély Joins Management of MetrioPharm AG as CEO
Thomas Christély to start as CEO of MetrioPharm AG on October 1, 2021 Dr. Wolfgang…
Persica Pharmaceuticals has completed the first stage of its clinical trial on unique injectable PP353, to treat chronic lower back pain
Persica Pharmaceuticals has completed the first stage of its clinical trial on unique injectable PP353,…
Regarding results of a share buy-back offer
Joint stock company “Olainfarm”, hereinafter referred to as – “the Company”, hereby informs that on…
Vistin Pharma ASA: Second quarter and first half 2021 financial results
Oslo, Norway, 19th of August 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy…
Eve & Co. Announces Revenues of $4.0M in the First Half of 2021 and Financial Results for the Six Months Ended June 30, 2021
STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”,…
Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the…
Coherus and Junshi Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy…
Paratek Pharmaceuticals Announces FDA Orphan Drug Designation for NUZYRA® (omadacycline) for the Treatment of Infections Caused by Nontuberculous Mycobacteria
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage…